Journal of Bone and Soft Tissue Tumors (JBST) License
Journal of Bone and Soft Tissue Tumors (JBST) by http://jbstjournal.com/ is licensed under https://creativecommons.org/licenses/by-nc-sa/4.0/
Based on a work at http://jbstjournal.com/.
Permissions beyond the scope of this license may be available at editor.jbst@gmail.com
Journal of Bone and Soft Tissue Tumors (JBST) is the official Journal of The Indian Musculo Skeletal Oncology Society
Editorial September – December 2019
Editorial | Volume 6 | Issue 1 | JBST September – December 2019 | Page 21 | Yogesh Panchwagh, Ashish Gulia, Ashok Shyam. 10.13107/jbst.2019.v05i03.014
Author: Dr. Yogesh Panchwagh[1], Dr. Ashish Gulia[2] & Dr. Ashok Shyam[3],[4]
[1]Orthopaedic Oncology Clinic, Pune, India.
[2]Orthopedic Oncology Services, Department of Surgical Oncology,
Tata Memorial Hospital, Mumbai.
[3]Indian Orthopaedic Research Group, Thane, India
[4]Sancheti Institute for Orthopaedics &Rehabilitation, Pune, India
Address of Correspondence
Dr. Yogesh Panchwagh.
Orthopaedic Oncology Clinic, 101, Vasant plot 29, Bharat Kunj
Society -2, Erandwana, Pune – 38, India.
Email: drpanchwagh@gmail.com
JBST has completed 5 years of publication. At present, JBST is indexed with Index Copernicus, ETH Bibliothek and Google scholar while the process of Pubmed indexation is in pipeline. Being the official journal of the Indian Musculoskeletal Oncology Society (IMSOS), most of the contributions to the journal have come from the members of IMSOS. There have been respectable international contributions too, mostly in form of review articles. We have noticed that the original research articles which JBST would like to emphasize on currently, are far and few to be submitted. We feel one of the main reason for this could be the pending pubmed indexation.
The awareness about need of publications is already there in the subcontinent. We believe that there is tremendous clinical work ongoing. The data analysis and writing of the manuscripts, which earlier was in the backseat, also is on the rise currently. Most of the educational institutes now look at the research done and published by the faculty to decide on multitude of factors like enhancing financial aid, giving additional manpower and deciding on appraisals and promotions. This boosts the need of doing more research and publishing it.
When an author thinks of sending his or her original research work to a journal, the main thing that plays a role is the indexation. It simply is a reflection on how the journal is valued, how much of a difference it’s making in the concerned field and whether the processes followed are up to a certain standard. This in turn gives a certain credibility to the journal. However, there were certain branches, orthopaedic oncology being one, where there was dearth of a journal dedicated to the field. JBST aimed at filling the void and giving an option to the researchers to publish their hard work which otherwise takes a long time to find its way to the online or print version of journals dedicated to a broader speciality. Our focus was and always will be quick turnaround time, good quality and being clinician and researcher friendly. Considering that most clinicians and students would have limited budget allocation, we have kept the publishing fees to the bare minimum. In fact, for the life members of the affiliated societies of the journal, JBST is happy to waive off the publishing fees.
As we continue to walk the path that we had set our feet on, we would like to thank all our authors, reviewers, editorial board members and readers for the pivotal role that they have played over the years in shaping JBST. With continued help and support by the above mentioned, we hope to continue improving and getting better.
Dr. Yogesh Panchwagh
Dr. Ashish Gulia
Dr. Ashok Shyam
[Full Text HTML] [Full Text PDF] [XML]
Like this:
Is Jungle Scout Really Worth? – Customer Reviews
Are you are planning to sell on Amazon? Then the most important factor you will think about is “How to find profitable products on Amazon?” Here is the solution! Instead of spending so many hours doing the product research, just use the smart jungle scout tools to do your product research in 10 mins. Jungle Scout is the most reliable and must-try tool to earn a pocket full of dollars on Amazon.
Jungle Scout comes in two different products, web apps and Chrome extensions which helps to filter amazon product categories and choose your own criteria of products. Find amazing discounts from time to time from us as sometimes we get exclusive deals to promote from Jungle Scout without partnership.
Jungle Scout honors and supports military members who actively make sacrifices so that we can enjoy the daily freedoms we do. As a small gesture to show our gratitude, we want to support active military and veterans leverage Amazon to build successful businesses. We are 100% sure jungle scout discount codes are best when compared to other services on our extensions and monthly web app subscriptions.
There is no other group with leadership, intelligence, work ethic, and discipline than someone who has served in the United States military. My father served for more than 20 years in the military, and I have seen those skills translate directly to a successful business career.
The FBA charges change as per the item, so to keep a net revenue on the exchange, the merchants must remember what they are offering and the amount they are offering it for. When they comprehend the sales, they can incorporate the stock of profitable items and furthermore lookout for competitors’ performance. A standout amongst the best ways by which dealers can recognize the best items to offer on Amazon is through Jungle Scout.
Is Jungle Scout Really Worth?
Jungle Scout is a wonderful time-saving tool with a great interface. The fact that it overlays the data on top of the existing browser page, makes it super quick and easy to search and track products on Amazon. It also captures and highlights the information for all variations of a product, when performing research.
On the downside, the Product Database may provide a great source of ideas, but it doesn’t cover everything that’s listed on Amazon. You may have to do your own manual researches to find something interesting and add them to your Product Tracker. Also, the sales estimate isn’t always accurate. You would need to keep a watch on the product through the tracker to get a better idea.
Pros:
Cons:
Pricing & Discounts:
Like this:
PhenQ – Weight Loss Pills Reviews & Results
Getting slim, losing weight, taking exercise and going on dieting seems to be a daunting task for most of the people who have put on a lot of weight. Though Genetics also play a huge role in our body structure and the shape of our core areas, things we can control are how much exercise we engage in and what we put in our bodies on daily basis. Our body is a complex machine that continuously works for us to live.
When you use cheap junk food as fuel, you get fatty and non-muscular as a result. It is similar to a vehicle in that matter. When you use unleaded 87 gas as compared to unleaded 92 gas, the same principle applies. The higher premium gas takes care of a vehicle better. This also applies to food and nutritional supplements that we take.
Unhealthy food and inferior quality supplements that are intended to cause weight loss, may be of poor quality and not able to do the job as the manufacturer marketed the medicine. One must be careful about what diet pills they take. That is why it’s important to read online reviews on products before you make a choice. After seeing many stellar reviews, this was found consistently to be a supplement product of high quality. Users consistently got the desired results they were hoping to achieve. This Phenq reviews 2019 answers all the questions that you might have about this product.
What Is PhenQ?
PhenQ is supplied and manufactured by WOLFSON BERG LIMITED. This company states they are proud of leading the supplements industry for over a decade. PhenQ is described as a weight loss pill that puts emphasis on many facets of weight loss and not just a typical appetite suppressant. They’re also proud of having helped over 190,000 customers!
Quality fat burners. It passes the eye test well enough and we look forward to reviewing the ingredients.
Clean label. We see everything in the formula, unlike other supplements that hide their ingredient doses.
Available in 3 sizes. 30 days, 90 days, and 150-day supplies, with the third size coming in with a freebie. We like deals like that!
DOES PHENQ WORK?
Yes, PhenQ really works. I too was a bit skeptical before using it, but I am very glad I ended up purchasing the 3 month supply. You should also know that the ingredients found in this product have been studied and tested extensively. Take a look at the results from the clinical studies. The formula will help you burn more calories throughout the day. Burn more calories, lose more weight. So in case you’ve been wondering.
Does Really PhenQ Work?
The fact that this product has over 190,000 satisfied customers and that it’s backed by science should answer your question. PhenQ works great when it comes to burning fat and suppressing appetite. However, it isn’t a magic pill. You will still need to diet and exercise.
But it’s going to help a lot throughout the process. For me, it made a major difference. Controlling my appetite was a real problem for me and this is where PhenQ made a huge difference. On the official website, you’ll find plenty of more people that have shared their results.
Like this:
Welcome to Taco Bell Survey & Feedback
People remember the days when they used to have paper reviews and surveys everywhere. People used to follow the traditional paper feedback methods in which we will be getting paper after our visit to any store. People even feel irritated when they were asked to do the paper surveys for a long time like 15-20 minutes. Most of the people don’t even show any kind of interest to take part in surveys. Then some people came with a creative solution and they are nothing but Online Surveys. Here we came up with a new topic called official tellthebell feedback and survey and its importance to customers.
The best thing in those online surveys is they can be completed in less time, even more, flexible as they will be in an easier format than compared to conventional paper surveys. Then every company started utilizing those surveys and have been following their outcomes. Taco bell a famous fast food restaurant chain that is an American origin is not an exception in this.
The publication’s annual fast food survey, released Wednesday, found giants like McDonald’s, KFC, Burger King, and Taco Bell all lagging behind their newer, hipper fast-casual counterparts, like In-N-Out Burger and Chipotle.
“After devouring 96,208 meals at 65 chains, Consumer Reports readers told us that quality of the food has become more important in their dining decisions, and convenience of location is less so,” the Consumer Reports release on the study read. “They could be reasons the traditional fast-food chains are losing their edge: Diners, especially younger adults in the millennial generation, maybe more willing to go out of their way to get a tasty meal.”
Taco Bell is an American chain of fast-food restaurants and is a California origin, also a subsidiary of Yum! Brands, Inc. These restaurants serve a variety of Tex-Mex(Texas-Mexican) foods that include tacos, burritos, quesadillas, nachos, novelty, and specialty items. Glenn Bell is the founder of Taco Bell Restaurant who is behind the success of the company.
They have started more than 7000+ stores all around the world from its origin in 1962. That figures can simply show how a successful brand TacoBell is and how it is growing day by day. And for such a large firm there is a tremendous requirement to know the feedback of their customers. Then in such a niche space, they started availing the services of tellthebell.com where people can give feedback on their visit to the TacoBell store.
The survey is conducted to know what the customers think about the food and services provided by Taco Bell, what their needs are. So, be honest and give your genuine feedback and accurate information as much as possible during the survey. It will be extremely helpful to assess the company’s performance and give the best experience for the diners.
Eligibility to enter the survey and the drawing
To join the survey, participants need to fulfill some requirements. You can also check the official sweepstakes rules by clicking the link at the bottom of the survey page.
Like this:
Primary Leiomyosarcoma of the Hip Bone: A Case Report and Literature Review
Vol 5 | Issue 3 | September – December 2019 | page: 5-7 | Dr. Francisco de Assis Serra Baima Filho.
Author: Francisco de Assis Serra Baima Filho [1].
[1] Department of Orthopedic Oncology, Aldenora Bello Oncology Institute of Maranhao, Brazil.
Address of Correspondence
Dr. Francisco de Assis Serra Baima Filho,
Department of Orthopedic Oncology, Aldenora Bello Orthopedic Oncology Institute of Maranhao (IMOAB), Brazil.
E-mail: assisbaima@gmail.com
Abstract
Introduction: Leiomyosarcoma is a rare smooth muscle mesenchymal neoplasm. The primary bone form is the rarest subtype. It mainly affects middle aged and female people. The most common complaint is the presence of a mass accompanied by pain. Diagnostic imaging and biopsy are required. The gold standard treatment is resection with oncologic margin.
Case Report: A 20-year-old female had a history of tumor mass and left hip pain beginning in September 2018.The patient showed the radiographic examination, osteolytic lesion of the left hip, and computed tomography scan of the abdomen with a solid expansive process measuring 15.8 cm left hip destruction and absence of organ damage. Biopsy and immunohistochemical result of leiomyosarcoma. Neoadjuvant chemotherapy was not effective. Thus, we opted for tumor resection with internal hemipelvectomy Type I.
Conclusion: Primary bone leiomyosarcoma is a rare malignant neoplasm which only shows tumoral resection with oncological margins as a curative treatment, thus the need for early diagnosis to allow adequate resection and lower patient morbidity.
Keywords: Leiomyosarcoma, case reports, rare diseases, literature review.
References
1. Gordon RW, Tirumani SH, Kurra V, Shinagare AB, Jagannathan JP, Hornick JL, et al. MRI, MDCT features, and clinical outcome of extremity leiomyosarcomas: Experience in 47 patients. Skeletal Radiol2014;43:615- 22.
2. Tahara K, Yamashita K, Hiwatashi A, Togao O, Kikuchi K, Endo M, et al. MR imaging findings of a leiomyosarcoma of the thoracic spine: A case report. Clin Neuroradiol 2016;26:229-33.
3. Mori T, Nakayama R, Endo M, Hiraga H, Tomita M, Fukase N, et al. Fortyeight cases of leiomyosarcoma of bone in Japan: A multicenter study from
the Japanese musculoskeletal oncology group. J Surg Oncol 2016;114:495-500.
4. Rekhi B, Kaur A, Puri A, Desai S, Jambhekar NA. Primary leiomyosarcoma of bone–a clinicopathologic study of 8 uncommon cases
with immunohistochemical analysis and clinical outcomes. Ann Diagn Pathol2011;15:147-56.
5. Potsi M, Stavrinou P, Patsinakidis N, Hatzibougias D, Foroglou N, Karayanopoulou G, et al. Primary osseous leiomyosarcoma of the spine: A
rare entity–case report and review of the literature. J Neurol Surg A Cent Eur Neurosurg2012;73:238-42.
6. Yang Y, Ma L, Li L, Liu H. Primary leiomyosarcoma of the spine: A case report and literature review. Medicine (Baltimore) 2017;96:e6227.
7. Zumárraga JP, Arouca MM, Baptista AM, Caiero MT, Rubio DE, Camargo OP. Primary leiomyosarcoma of bone: Clinicopathologic and
prognostic factors analysis in a single institution. Acta Ortopédica Bras 2019;27:152-5.
8. Recine F, Bongiovanni A, Casadei R, Pieri F, Riva N, De Vita A, et al. Primary leiomyosarcoma of the bone: A case report and a review of the literature. Medicine (Baltimore) 2017;96:e8545.
(Abstract Full Text HTML) (Download PDF)
Like this:
Osteoid Osteoma Radiofrequency Ablation Treatment using a Kirschner Wireguided with a Scope: A Case Report and Literature Review
Vol 5 | Issue 3 | September – December 2019 | page: 2-4 | Dr. Francisco de Assis Serra Baima Filho.
Author: Francisco de Assis Serra Baima Filho [1].
[1] Department of Orthopedic Oncology, Aldenora Bello Oncology Institute of Maranhao, Brazil.
Address of Correspondence
Dr. Francisco de Assis Serra Baima Filho,
Department of Orthopedic Oncology, Aldenora Bello Orthopedic Oncology Institute of Maranhao (IMOAB), Brazil.
E-mail: assisbaima@gmail.com
Abstract
Introduction: Osteoid osteoma is a benign tumor and is the third most common bone tumor. It is <2cm and characterized by very intense clinical pain at night which lets up after taking two nonsteroid anti-inflammatory drugs. Conventionally, the surgical treatment performed was resection or curettage. At present, the recommended treatment is computed tomography (CT)-guided radio frequency due to the high efficacy rate and low comorbidity.
Case Report: A 29-year-old male patient diagnosed with an osteoid osteoma in a small right femoral trochanter. Due to the location of the tumor, we opted for a percutaneous treatment, but it was not possible to be submitted to CT-guided radio frequency due to the high costs. Thus, the scope-guided Kirschner wire radioablation technique was developed.
Discussion: At present, CT-guided radio frequency ablation is the most commonly used method due to its safety, high efficacy (over 90%), and minimally invasive. However, there are disadvantages: Problems with sterility of the radiological set, radiation, and high risk of thermal the skin and soft tissue necrosis. New treatment methods are under development, but they are even more costly.
Conclusion: Due to its high costs, many patients, especially from underdeveloped countries, donot undergo this treatment and are reserved to open surgical treatment with resection or curettage. Therefore, the development of low-cost minimally invasive percutaneous techniques is necessary.
Keywords: Osteoid osteoma (MeSH ID: D010017), case report (MeSH ID: D002363), rare diseases (MeSH ID: D035583), literature review (MeSH ID: D016454).
References
1. Göksel F, Aycan A, Ermutlu C, Gölge UH, Sarisözen B. Comparison of radiofrequency ablation and curettage in osteoid osteoma in children. Acta Ortop Bras 2019;27:100-3.
2. Gurkan V, Erdogan O. Foot and ankle osteoid osteomas. J Foot Ankle Surg 2018;57:826-32.
3. Rinzler ES, Shivaram GM, Shaw DW, Monroe EJ, Koo KS. Microwave ablation of osteoid osteoma: Initial experience and efficacy. Pediatr Radiol 2019;49:566-70.
4. Hage AN, Chick JF, Gemmete JJ, Grove JJ, Srinivasa RN. Percutaneous radiofrequency ablation for the treatment of osteoid osteoma in children and adults: A comparative analysis in 92 patients. Cardiovasc Intervent Radiol 2018;41:1384-90.
5. Santiago E, Pauly V, Brun G, Guenoun D, Champsaur P, Le Corroller T. Percutaneous cryoablation for the treatment of osteoid osteoma in the adult population. Eur Radiol 2018;28:2336-44.
6. Shields DW, Sohrabi S, Crane EO, Nicholas C, Mahendra A. Radiofrequency ablation for osteoid osteoma-recurrence rates and predictive factors. Surgeon 2018;16:156-62.
7. Cuesta HE, Villagran JM, Horcajadas AB, Kassarjian A, Caravaca GR. Percutaneous radiofrequency ablation in osteoid ostema: Tips and tricks in special scenarios. Eur J Radiol 2018;102:169-75.
8. Miyazaki M, Saito K, Yanagawa T, Chikuda H, Tsushima Y. Phase I clinical trial of percutaneous cryoablation for osteoid osteoma. Jpn J Radiol 2018;36:669-75.
9. Erdogan O, Gurkan V. Hand osteoid osteoma: Evaluation of diagnosis and treatment. Eur J Med Res 2019;24:1-5.
10. Doyle AJ, Graydon AJ, Hanlon MM, French JG. Radiofrequency ablation of osteoid osteoma: Aiming for excellent outcomes in an Australasian context. J Med Imaging Radiat Oncol 2018;62:789-93.
(Abstract Full Text HTML) (Download PDF)
Like this: